Activation of a metabolic gene regulatory network downstream of mTOR complex 1

Katrin Düvel1, Jessica L Yecies, Suchithra Menon

  • 1Department of Genetics and Complex Diseases, Harvard School of Public Health, Boston, MA 02115, USA.

Molecular Cell
|July 31, 2010
PubMed

Insights

Aberrant activation of the mammalian target of rapamycin complex 1 (mTORC1) stimulates key metabolic pathways like glycolysis and lipid synthesis. This mTORC1 activation drives cell proliferation and contributes to various diseases.

Area of Science:

  • Cellular metabolism
  • Molecular biology
  • Cancer research

Background:

  • Aberrant activation of the mammalian target of rapamycin complex 1 (mTORC1) is prevalent in pathological conditions such as cancer and obesity.
  • The precise intracellular effects of mTORC1 activation are not fully understood.

Purpose of the Study:

  • To elucidate the cell-intrinsic consequences of mTORC1 activation.
  • To identify the metabolic pathways and transcriptional programs regulated by mTORC1.

Main Methods:

  • Unbiased genomic, metabolomic, and bioinformatic analyses were employed.
  • Investigated the role of hypoxia-inducible factor (HIF1alpha) and sterol regulatory element-binding proteins (SREBP1 and SREBP2) in mediating mTORC1 effects.
  • Assessed the contribution of S6 kinase 1 (S6K1) in SREBP activation.

Main Results:

  • mTORC1 activation was found to be sufficient for stimulating glycolysis, the pentose phosphate pathway, and de novo lipid biosynthesis.
  • A transcriptional program involving HIF1alpha and SREBP1/2 targets was activated by mTORC1.
  • SREBP1 and SREBP2 were identified as promoters of cell proliferation downstream of mTORC1, with S6K1 mediating their activation.

Conclusions:

  • mTORC1 activation orchestrates specific metabolic and anabolic processes beyond protein synthesis.
  • These mTORC1-driven pathways, including those regulated by SREBP transcription factors, play a significant role in cell proliferation and are implicated in human diseases.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Regulation of Metabolism01:19

Regulation of Metabolism

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...